| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $224.2M | +4.2% | +20.8% |
| Cost of Revenue | $46.4M | -6.4% | +6.2% |
| Gross Profit | $177.8M | +7.3% | +25.2% |
| R&D Expense | $51.4M | -6.3% | +6.1% |
| SG&A Expense | $28.7M | -0.9% | +12.2% |
| Operating Income | -$3.4M | +84.6% | +84.4% |
| Interest Expense | $3.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $315.9M | +11.1% | +27.3% |
| Accounts Receivable | $144.4M | +18.8% | +4.7% |
| Current Assets | $1.09B | +6.8% | +10.5% |
| Total Assets | $1.41B | +4.9% | +8.4% |
| Current Liabilities | $692.5M | +4.6% | +28.4% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $46.2M | -8.3% | +144.1% |
| Capital Expenditures | $91K | -90.9% | -62.6% |
| Investing Cash Flow | -$10.1M | -136.0% | +79.6% |
| Financing Cash Flow | -$3.6M | +59.9% | -141.1% |
| Free Cash Flow | $46.1M | -6.6% | +146.8% |
| +0.0% |
| +0.1% |
| Pre-tax Income | $2.2M | +112.2% | +113.5% |
| Income Tax | -$626K | -137.5% | -165.3% |
| Net Income | $2.8M | +114.4% | +116.4% |
| EPS (Basic) | $0.05 | +114.3% | +116.1% |
| EPS (Diluted) | $0.05 | +114.3% | +116.1% |
| $1.45B |
| +2.5% |
| +7.0% |
| Stockholders' Equity | -$36.9M | +44.5% | +27.3% |